Ultrasonographic Insulin Versus Dexamethasone Injection With Local Anestheticss in Diabetic Patients With Mild to Moderate Median Nerve Entrapement Neuropathy .

March 1, 2021 updated by: Mina Maher, Minia University
Insulin injection in carpal tunnel compared with dexamethsone in diabetic patients

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Trial to decrease median nerve entrapement neuropathy recurrence using insulin co-injection

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • ALMinya, Egypt, 6115
        • Recruiting
        • Minia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All diabetic patients with carpal tunnel syndrome

Exclusion Criteria:

  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: dexamethasone
dexamethasone with local anesthetics injected for carpal tunnel relief
ACTIVE_COMPARATOR: Insulin group
insulin with local anesthetics and dexamehtasone injected for carpal tunnel relief
Drug: insulin injection
Carpal tunnel syndrome sonagraphic injection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain relief
Time Frame: 12 weeks
consumption analgesics
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Minia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 28, 2021

Primary Completion (ANTICIPATED)

April 5, 2021

Study Completion (ANTICIPATED)

April 30, 2021

Study Registration Dates

First Submitted

February 24, 2021

First Submitted That Met QC Criteria

March 1, 2021

First Posted (ACTUAL)

March 4, 2021

Study Record Updates

Last Update Posted (ACTUAL)

March 4, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 212/2-2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Neuropathic

Clinical Trials on insulin injection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe